Celltrion launches biosimilar of AbbVies blockbuster drug Humira in ... - Reuters
FMEA Stock | EUR 22.20 0.40 1.77% |
Roughly 62% of Fresenius Medical's investor base is looking to short. The analysis of current outlook of investing in Fresenius Medical Care suggests that many traders are alarmed regarding Fresenius Medical's prospects. The current market sentiment, together with Fresenius Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Fresenius Medical Care stock news signals to limit their universe of possible portfolio assets.
Fresenius Medical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Fresenius daily returns and investor perception about the current price of Fresenius Medical Care as well as its diversification or hedging effects on your existing portfolios.
Fresenius |
Celltrion launches biosimilar of AbbVies blockbuster drug Humira in ... Reuters
Read at news.google.com
![]() |
Fresenius Medical Fundamental Analysis
We analyze Fresenius Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Fresenius Medical is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Fresenius Medical Care Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Fresenius Medical stock to make a market-neutral strategy. Peer analysis of Fresenius Medical could also be used in its relative valuation, which is a method of valuing Fresenius Medical by comparing valuation metrics with similar companies.
Peers
Fresenius Medical Related Equities
DT7 | CN DATANG | 4.35 | ||||
5NU | CapitaLand Investment | 1.16 | ||||
GUG | Guangdong Investment | 1.45 | ||||
6E6 | ATON GREEN | 2.26 | ||||
DT7 | China Datang | 4.00 |
Complementary Tools for Fresenius Stock analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |